XML 36 R95.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combinations - MedReleaf Corp. ("MedReleaf") (Details)
$ in Thousands
 1 Months Ended 11 Months Ended
Jul. 24, 2018
CAD ($)
Jun. 30, 2019
CAD ($)
Jul. 25, 2018
CAD ($)
shares
Disclosure of detailed information about business combination [line items]      
Common shares issued   $ 3,036,810  
Replacement share-based awards   83,037  
Final      
Total consideration paid   3,181,453  
Property, plant and equipment   167,051  
Loans and borrowings   (6,301)  
Provisions   (4,200)  
Deferred tax liability   (78,551)  
Goodwill   2,416,940  
MedReleaf Corp. (“MedReleaf”)      
Disclosure of detailed information about business combination [line items]      
Number of shares issued for acquisition (in shares) | shares     30,843,353
Common shares issued     $ 2,568,634
Replacement share-based awards     75,373
Provisional allocation at acquisition      
Consideration payable     2,644,115
Loans receivable     845
Property, plant and equipment     134,414
Intangible assets     335,988
Loans and borrowings     (845)
Provision     0
Deferred tax liability     (75,920)
Goodwill     2,086,382
Adjustments      
Consideration payable     (108)
Loans receivable     (845)
Property, plant and equipment     (15,090)
Intangible assets     (51,001)
Loans and borrowings     845
Provision     (4,200)
Deferred tax liability     15,935
Goodwill     54,248
Final      
Total consideration paid     2,644,007
Loans receivable     0
Property, plant and equipment     119,324
Intangible assets     284,987
Loans and borrowings     0
Provisions     (4,200)
Deferred tax liability     (59,985)
Goodwill     2,140,630
Revenue of combined entity as if combination occurred at beginning of period   113,300  
Loss of combined entity as if combination occurred at beginning of period   $ 25,100  
Revenue of acquiree prior to acquisition date $ 4,500    
Loss of acquiree prior to acquisition date $ 17,600    
MedReleaf Corp. (“MedReleaf”) | Stock options      
Disclosure of detailed information about business combination [line items]      
Replacement share-based awards     53,800
MedReleaf Corp. (“MedReleaf”) | Performance options      
Disclosure of detailed information about business combination [line items]      
Replacement share-based awards     2,000
MedReleaf Corp. (“MedReleaf”) | Warrants      
Disclosure of detailed information about business combination [line items]      
Replacement share-based awards     $ 19,600